Topper James N - Insider Stock Trading - OpenInsider

CIK: 1341382 - Address: , 1001 Page Mill Rd, Building 4, Suite B, Palo Alto, CA 94304

9 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
6/26/25 19:41	6/24/25	NAMS	Newamsterdam Pharma Co N.V.	P7	Health	Drug	Pharmaceutical Preparations	Topper James N	CA	D		P.m	69	18.38	0	4	0	6,827	I
6/18/25 16:42	6/16/25	NAMS	Newamsterdam Pharma Co N.V.	P7	Health	Drug	Pharmaceutical Preparations	Topper James N	CA	D		P	167	19.50	0	9	0	6,823	I
5/23/25 16:06	5/21/25	PHAT	Phathom Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Topper James N	CA	D		P	15	3.86	0	4	0	5,923	I
5/15/25 16:17	5/13/25	PHAT	Phathom Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Topper James N	CA	D		P.m	24	3.30	0	7	0	5,919	I
5/13/25 16:13	5/9/25	PHAT	Phathom Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Topper James N	CA	D		P.m	153	3.17	0	48	1	5,912	I
3/28/25 17:36	3/26/25	NAMS	Newamsterdam Pharma Co N.V.	P7	Health	Drug	Pharmaceutical Preparations	Topper James N	CA	D		P	26	22.49	0	1	0	6,815	I
3/6/25 17:32	3/4/25	NAMS	Newamsterdam Pharma Co N.V.	P7	Health	Drug	Pharmaceutical Preparations	Topper James N	CA	D		P	84	21.02	0	4	0	6,813	I
4/29/24 16:32	4/25/24	ALPN	Alpine Immune Sciences, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Topper James N	WA	D		S.d	-1	64.57	0	0	0	2,829	I
3/28/24 16:30	3/26/24	NAMS	Newamsterdam Pharma Co N.V.	P7	Health	Drug	Pharmaceutical Preparations	Topper James N	WA	D		P	181	21.50	0	8	0	6,809	I

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact